BTLA antibody (C-Term)
-
- Target See all BTLA Antibodies
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Binding Specificity
- C-Term
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BTLA antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA
- Cross-Reactivity
- Human
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from C-terminal of Human BTLA.
- Isotype
- IgG
- Top Product
- Discover our top product BTLA Primary Antibody
-
-
- Application Notes
- WB:1:500-1:3000,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BTLA (B and T Lymphocyte Associated (BTLA))
- Alternative Name
- BTLA (BTLA Products)
- Synonyms
- BTLA antibody, BTLA1 antibody, CD272 antibody, A630002H24 antibody, B and T lymphocyte associated antibody, BTLA antibody, Btla antibody
- Background
-
Background: Lymphocyte inhibitory receptor which inhibits lymphocytes during immune response.
Watanabe N., Nat. Immunol. 4:670-679(2003).
Mao Y., Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
Oaks M.K., Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.Aliases: B and T lymphocyte associated protein antibody, B and T lymphocyte attenuator antibody, B and T lymphocyte associated antibody, B- and T-lymphocyte attenuator antibody, B- and T-lymphocyte-associated protein antibody, BTLA antibody, BTLA_HUMAN antibody, BTLA1 antibody, CD272 antibody, CD272 antigen antibody, FLJ16065 antibody, MGC129743 antibody
- UniProt
- Q7Z6A9
- Pathways
- Cancer Immune Checkpoints
-